The largest database of trusted experimental protocols

Ofloxacin

Manufactured by Meilun
Sourced in China

Ofloxacin is a synthetic antibacterial agent that belongs to the class of fluoroquinolone drugs. It functions as a broad-spectrum antibiotic, inhibiting the activity of bacterial DNA gyrase and topoisomerase IV, which are essential enzymes for bacterial DNA replication and transcription. Ofloxacin demonstrates effectiveness against a wide range of gram-positive and gram-negative bacteria.

Automatically generated - may contain errors

3 protocols using ofloxacin

1

Graphene Oxide-based Fluoroquinolone Detection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sarafloxacin (SAR), ofloxacin (OFL), gatifloxacin (GAT), enrofloxacin (ENR), ciprofloxacin (CIP), and tetracycline (TC) were purchased from Meilun Biological Technology Corp. (Dalian, China). Dopamine (DA), tris(hydroxymethyl) aminomethane hydrochloride (Tris-HCl), and phthalic acid (PA) were obtained from Aladdin (Shanghai, China). Graphene oxide (GO) power was obtained from Nanjing XFNANO Materials Tech Co., Ltd (Nanjing, China). Deionized water (DI) used was prepared by a Milli-Q® ultrapure water system (Bedford, MA USA).
+ Open protocol
+ Expand
2

Antimicrobial Susceptibility of R. anatipestifer

Check if the same lab product or an alternative is used in the 5 most similar protocols
MICs of nalidixic acid (Aladdin, USA), ciprofloxacin (Aladdin, USA), enrofloxacin (Aladdin, USA) and ofloxacin (Meilunbio, China) for 162 R. anatipestifer isolates were determined using the standard microscale broth dilution method, performed according to Clinical and Laboratory Standard Institute (CLSI) criteria [23 ], to analyze the antimicrobial susceptibility of randomly collected isolates between 1932 and 2018.
To explore whether the R. anatipestifer site-directed in vivo mutants showed cross-resistance phenotypes with other nonquinolone antibiotics, the MICs of several other nonquinolone antibiotics such as ampicillin (Aladdin, USA), ceftiofur (Meilunbio, China), amikacin (Meilunbio, China), florfenicol (Aladdin, USA), doxycycline (Meilunbio, China) and lincomycin (Aladdin, USA) were determined for these strains.
The concentration of these antimicrobial agents in 96-well plates ranged from 0.25 to 1024 μg/mL, except that of nalidixic acid, which ranged from 0.5 to 2048 μg/mL. E. coli ATCC 25922 was used for quality control. The experiments were repeated in triplicate.
+ Open protocol
+ Expand
3

Antimicrobial Susceptibility Testing Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Susceptibility to antimicrobials was determined in triplicate using the standard agar dilution method recommended by the Clinical and Laboratory Standards Institute (CLSI, 2020) [66 ]. The following eighteen antimicrobials were tested: kanamycin (KAN), gentamicin (GEN), erythromycin (ERY), azithromycin (AZM), norfloxacin (NOR), ofloxacin (OFX), ciprofloxacin (CIP), lomefloxacin (LOM), levofloxacin (LEV), sulfadiazine (SD), trimethoprim (TMP), ceftriaxone (CRO), cefixime (CFM), ampicillin (AMP), amoxicillin (AML), aztreonam (ATM), imipenem (IPM) and tetracycline (TET) (Meilun Biotechnology Co., LTD, Dalian, China). The isolates were grown on TSA plates, suspended in stroke-physiological saline solution to a turbidity equivalent to 0.5 McFarland Standard, and inoculated onto Mueller-Hinton agar plates using a multipoint inoculator (MIT-60P; Sakuma Seisakusyo, Tokyo, Japan). The final inoculum was approximately 104 CFU per spot. Plates were incubated at 37 °C for 16–18 h. The range of 2-fold concentrations used to determine the susceptibility was determined by CLSI criteria. In addition, the results were interpreted in accordance with CLSI criteria (Supplementary Table S3). E. coli ATCC25922 and E. faecalis ATCC29212 were used as quality control strains.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!